Establishment Net Debt from 2010 to 2024

ESTA Stock

USD 44.64 0.23 0.51%

Establishment Labs' Net Debt is increasing over the years with slightly volatile fluctuation. Overall, Net Debt is expected to go to about 159.8 M this year. Net Debt is the total debt of Establishment Labs Holdings minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2017-03-31

Previous Quarter

123.2 M

Current Value

143 M

Quarterly Volatility

65.8 M

Covid

Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment Labs' main balance sheet or income statement drivers, such as Interest Income of 568 K, Interest Expense of 9.4 M or Selling General Administrative of 74 M, as well as many indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0 or PTB Ratio of 37.83. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.

Check out the analysis of Establishment Labs Correlation against competitors.

Latest Establishment Labs' Net Debt Growth Pattern

Below is the plot of the Net Debt of Establishment Labs Holdings over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Establishment Labs' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Establishment Labs' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Establishment Net Debt Regression Statistics

	Arithmetic Mean	43,266,697
	Geometric Mean	30,197,919
	Coefficient Of Variation	131.68
	Mean Deviation	39,265,781
	Median	37,670,000
	Standard Deviation	56,971,570
	Sample Variance	3245.8T
	Range	192.6M
	R-Value	0.40
	Mean Square Error	2931.8T
	R-Squared	0.16
	Significance	0.14
	Slope	5,115,751
	Total Sum of Squares	45440.6T

Establishment Net Debt History

	2024	159.8 M
	2023	152.2 M
	2022	112.3 M
	2021	391 K
	2020	-32.8 M
	2019	10.5 M
	2018	-30.3 M

Other Fundumenentals of Establishment Labs

Net Debt To E B I T D A

Establishment Labs Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Capital Surpluse	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Invested Capital	Net Working Capital	Long Term Debt Total	Capital Stock
Total Assets		0.61	0.42	0.24	0.45	-0.93	0.74	0.98	0.87	0.9	0.81	-0.47	-0.84	0.98	0.39	-0.89	0.95	0.98	0.8	0.88	0.99	0.94	0.89	0.91
Total Stockholder Equity	0.61		0.94	-0.26	-0.27	-0.5	0.25	0.52	0.79	0.5	0.21	-0.2	-0.8	0.73	0.4	-0.85	0.53	0.73	0.19	0.34	0.6	0.8	0.61	0.41
Net Tangible Assets	0.42	0.94		-0.38	-0.55	-0.24	-0.07	0.32	0.63	0.25	-0.08	0.13	-0.68	0.57	0.38	-0.71	0.31	0.56	-0.1	0.07	0.41	0.65	0.47	0.17
Current Deferred Revenue	0.24	-0.26	-0.38		0.48	-0.29	0.39	0.29	0.27	0.42	0.43	-0.28	-0.24	0.14	-0.71	-0.01	0.37	0.11	0.42	0.34	0.18	-0.01	0.03	0.32
Net Debt	0.45	-0.27	-0.55	0.48		-0.66	0.85	0.54	0.19	0.61	0.87	-0.76	-0.12	0.32	0.03	-0.17	0.52	0.33	0.88	0.78	0.48	0.25	0.32	0.62
Retained Earnings	-0.93	-0.5	-0.24	-0.29	-0.66		-0.91	-0.93	-0.81	-0.97	-0.94	0.72	0.76	-0.9	-0.31	0.83	-0.91	-0.91	-0.93	-0.97	-0.93	-0.86	-0.84	-0.93
Accounts Payable	0.74	0.25	-0.07	0.39	0.85	-0.91		0.78	0.6	0.87	0.95	-0.91	-0.53	0.67	0.14	-0.58	0.81	0.69	0.95	0.92	0.75	0.62	0.61	0.86
Net Receivables	0.98	0.52	0.32	0.29	0.54	-0.93	0.78		0.85	0.91	0.83	-0.49	-0.82	0.94	0.32	-0.85	0.96	0.95	0.83	0.89	0.97	0.89	0.88	0.9
Good Will	0.87	0.79	0.63	0.27	0.19	-0.81	0.6	0.85		0.87	0.62	-0.42	-1.0	0.91	0.11	-0.95	0.84	0.9	0.6	0.7	0.83	0.88	0.78	0.69
Capital Surpluse	0.9	0.5	0.25	0.42	0.61	-0.97	0.87	0.91	0.87		0.9	-0.69	-0.83	0.88	0.12	-0.84	0.89	0.87	0.89	0.93	0.88	0.82	0.79	0.87
Total Liab	0.81	0.21	-0.08	0.43	0.87	-0.94	0.95	0.83	0.62	0.9		-0.8	-0.56	0.73	0.21	-0.62	0.8	0.73	1.0	0.99	0.82	0.68	0.67	0.86
Deferred Long Term Liab	-0.47	-0.2	0.13	-0.28	-0.76	0.72	-0.91	-0.49	-0.42	-0.69	-0.8		0.35	-0.42	-0.05	0.4	-0.55	-0.44	-0.8	-0.75	-0.49	-0.41	-0.34	-0.61
Short Long Term Debt	-0.84	-0.8	-0.68	-0.24	-0.12	0.76	-0.53	-0.82	-1.0	-0.83	-0.56	0.35		-0.9	-0.11	0.95	-0.81	-0.88	-0.54	-0.65	-0.81	-0.87	-0.76	-0.64
Total Current Assets	0.98	0.73	0.57	0.14	0.32	-0.9	0.67	0.94	0.91	0.88	0.73	-0.42	-0.9		0.42	-0.95	0.91	0.99	0.72	0.82	0.98	0.98	0.9	0.85
Treasury Stock	0.39	0.4	0.38	-0.71	0.03	-0.31	0.14	0.32	0.11	0.12	0.21	-0.05	-0.11	0.42		-0.4	0.2	0.44	0.21	0.31	0.46	0.55	0.47	0.3
Short Term Debt	-0.89	-0.85	-0.71	-0.01	-0.17	0.83	-0.58	-0.85	-0.95	-0.84	-0.62	0.4	0.95	-0.95	-0.4		-0.79	-0.94	-0.6	-0.73	-0.88	-0.96	-0.86	-0.69
Intangible Assets	0.95	0.53	0.31	0.37	0.52	-0.91	0.81	0.96	0.84	0.89	0.8	-0.55	-0.81	0.91	0.2	-0.79		0.93	0.79	0.83	0.92	0.83	0.83	0.94
Common Stock	0.98	0.73	0.56	0.11	0.33	-0.91	0.69	0.95	0.9	0.87	0.73	-0.44	-0.88	0.99	0.44	-0.94	0.93		0.71	0.81	0.97	0.97	0.92	0.88
Property Plant Equipment	0.8	0.19	-0.1	0.42	0.88	-0.93	0.95	0.83	0.6	0.89	1.0	-0.8	-0.54	0.72	0.21	-0.6	0.79	0.71		0.98	0.81	0.67	0.64	0.85
Long Term Debt	0.88	0.34	0.07	0.34	0.78	-0.97	0.92	0.89	0.7	0.93	0.99	-0.75	-0.65	0.82	0.31	-0.73	0.83	0.81	0.98		0.89	0.79	0.75	0.87
Net Invested Capital	0.99	0.6	0.41	0.18	0.48	-0.93	0.75	0.97	0.83	0.88	0.82	-0.49	-0.81	0.98	0.46	-0.88	0.92	0.97	0.81	0.89		0.95	0.89	0.9
Net Working Capital	0.94	0.8	0.65	-0.01	0.25	-0.86	0.62	0.89	0.88	0.82	0.68	-0.41	-0.87	0.98	0.55	-0.96	0.83	0.97	0.67	0.79	0.95		0.88	0.78
Long Term Debt Total	0.89	0.61	0.47	0.03	0.32	-0.84	0.61	0.88	0.78	0.79	0.67	-0.34	-0.76	0.9	0.47	-0.86	0.83	0.92	0.64	0.75	0.89	0.88		0.82
Capital Stock	0.91	0.41	0.17	0.32	0.62	-0.93	0.86	0.9	0.69	0.87	0.86	-0.61	-0.64	0.85	0.3	-0.69	0.94	0.88	0.85	0.87	0.9	0.78	0.82

Click cells to compare fundamentals

About Establishment Labs Financial Statements

Establishment Labs stakeholders use historical fundamental indicators, such as Establishment Labs' Net Debt, to determine how well the company is positioned to perform in the future. Although Establishment Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Establishment Labs' assets and liabilities are reflected in the revenues and expenses on Establishment Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Establishment Labs Holdings. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	152.2 M	159.8 M
Net Debt To EBITDA	(2.53)	(2.40)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
MSFT	Microsoft

When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:

How To Invest In Establishment

Details

Is Establishment Stock a good investment?

Details

What is Establishment Labs' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Establishment Labs Correlation against competitors.

You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

5.633

Quarterly Revenue Growth

(0.09)

Return On Assets

(0.13)

Return On Equity

(1.67)

The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Establishment Net Debt from 2010 to 2024

Latest Establishment Labs' Net Debt Growth Pattern

Establishment Net Debt Regression Statistics

Establishment Net Debt History

Other Fundumenentals of Establishment Labs

Establishment Labs Net Debt component correlations

About Establishment Labs Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY